CR7720A - 2-HYDROXI-1,3- DIAMINOALCANE OIL - Google Patents

2-HYDROXI-1,3- DIAMINOALCANE OIL

Info

Publication number
CR7720A
CR7720A CR7720A CR7720A CR7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A
Authority
CR
Costa Rica
Prior art keywords
diaminoalcane
hydroxi
oil
compounds
disclosed
Prior art date
Application number
CR7720A
Other languages
Spanish (es)
Inventor
Maillard Michel
T Baldwin Eric
P Beck James
Hughes Robert
Varghese John
R Pulley Shon
Tenbrink Ruth
Original Assignee
Elan Pharm Inc
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc, Upjohn Co filed Critical Elan Pharm Inc
Publication of CR7720A publication Critical patent/CR7720A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se divulgan compuestos de la Formula I. Donde las variables Z,X, R15, R2, R3, Rc son definidas aqui. Los compuestos divulgados aqui son inhibidores de la enzima beta secretasa y por lo tanto, son utiles para el tratamiento de la enfermedad del Alzheimer y otras enfermedades caracterizadas por la deposicion del peptido A beta en un mamifero.Compounds of Formula I are disclosed. Where the variables Z, X, R15, R2, R3, Rc are defined herein. The compounds disclosed herein are inhibitors of the beta secretase enzyme and are therefore useful for the treatment of Alzheimer's disease and other diseases characterized by the deposition of the beta A peptide in a mammal.

CR7720A 2002-09-10 2005-03-09 2-HYDROXI-1,3- DIAMINOALCANE OIL CR7720A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40945302P 2002-09-10 2002-09-10

Publications (1)

Publication Number Publication Date
CR7720A true CR7720A (en) 2005-07-14

Family

ID=35353421

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7720A CR7720A (en) 2002-09-10 2005-03-09 2-HYDROXI-1,3- DIAMINOALCANE OIL

Country Status (5)

Country Link
CN (1) CN100384824C (en)
AP (1) AP2005003247A0 (en)
CR (1) CR7720A (en)
TN (1) TNSN05067A1 (en)
ZA (1) ZA200501991B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010030538A1 (en) * 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
DE102011087987A1 (en) * 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
SG10202100751YA (en) 2016-07-29 2021-03-30 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
WO2018019291A1 (en) * 2016-07-29 2018-02-01 The Hong Kong University Of Science And Technology C(sp3)-c(sp2) cross-coupling reaction of organozinc reagents and heterocyclic (pseudo)halides
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
CN113189089B (en) * 2021-03-19 2022-05-17 四川轻化工大学 A kind of ozone detection reagent and preparation device and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482947A (en) * 1990-11-19 1996-01-09 Talley; John J. Retroviral protease inhibitors
AU749281B2 (en) * 1997-02-04 2002-06-20 Regents Of The University Of California, The Nanomolar, non-peptide inhibitors of cathepsin D

Also Published As

Publication number Publication date
CN100384824C (en) 2008-04-30
CN1694870A (en) 2005-11-09
ZA200501991B (en) 2006-01-25
TNSN05067A1 (en) 2007-05-14
AP2005003247A0 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
ECSP055696A (en) 2-HYDROXI-1, 3-DIAMINOALCAN OIL
UY28101A1 (en) SUBSTITUTED UREAS AND USEFUL CARBAMATES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
UY28280A1 (en) 2- HYDROXI - 3- DIAMINOALCANOS DE BENZAMIDA
UY28279A1 (en) FENACILO 2 -HIDROXI - 3 - DIAMINOALCANOS
UY27918A1 (en) BENZODIOXOL DERIVATIVES
UY27774A1 (en) METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA
UY26480A1 (en) N - (5 - (5 - ALKYL - 2 - OXAZOLYL) METHYL) THIO) - 2 - THIAZOLYL) - CYCLONE-DEPENDENT KINASE CARBOXAMIDE
ECSP044992A (en) INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
ECSP055719A (en) TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
UY28450A1 (en) 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
UY27338A1 (en) NEW DERIVATIVES OF SULPHONIC ACID
DE60210614D1 (en) MACROCYCLES SUITABLE FOR THE TREATMENT OF ALZHEIMER DISEASE
WO2005095326A3 (en) 2-amino- and 2-thio-substituted 1,3-diaminopropanes
CR7720A (en) 2-HYDROXI-1,3- DIAMINOALCANE OIL
UY27451A1 (en) 2,5-DIAMIDOINDOLES REPLACED AND ITS USE
BR9508342A (en) Organic compounds
SV2005001840A (en) OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS - DOCKET 17005
ATE464048T1 (en) TREATMENT OF ALZHEIMER'S DISEASE AND RELATED CONDITIONS
GT200300066A (en) CYCLOPENTENE DERIVATIVES
BR0314714A (en) Compounds for the treatment of alzheimer's disease
PA8558901A1 (en) NEW HEXACICLIC COMPOUNDS
ATE359995T1 (en) AMINE 1,2 AND 1,3-DIOL COMPOUNDS AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
DE60210769D1 (en) USE OF BICYCLIC COMPOUNDS FOR THE TREATMENT OF ALZHEIMER
GT200500062A (en) 2-HIROXIDE-1,3 DIAMINOALCANOS ACETYL
WO2004037179A3 (en) Substituted peptides useful in the treatment of alzheimer’s disease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)